Acuta Capital Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-122,900
| Closed | -$6.28M | – | 36 |
|
|
2024
Q4 | $6.28M | Sell |
122,900
-8,800
| -7% | -$450K | 6.32% | 4 |
|
|
2024
Q3 | $6.73M | Sell |
131,700
-3,441
| -3% | -$176K | 5.45% | 6 |
|
|
2024
Q2 | $6.05M | Buy |
135,141
+56,738
| +72% | +$2.54M | 5.1% | 6 |
|
|
2024
Q1 | $3.67M | Sell |
78,403
-9,097
| -10% | -$426K | 2.38% | 17 |
|
|
2023
Q4 | $3.11M | Sell |
87,500
-6,500
| -7% | -$231K | 1.75% | 22 |
|
|
2023
Q3 | $2.8M | Buy |
+94,000
| New | +$2.8M | 1.87% | 18 |
|